Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
- Status
- COMPLETED
- Phase
- N/A
'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
- Status
- COMPLETED
- Phase
- N/A
PF-07104091 as a Single Agent and in Combination Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor
- Status
- COMPLETED
- Phase
- N/A
Neuroinflammation and Age-associated Brain Pathology: Two Potential Mechanisms of Cognitive Impairment in Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Living WELL: A Web-Based Program for Ovarian Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Tumor Grade Determines PD-1/PDL-1 Expression
- Status
- UNKNOWN
- Phase
- N/A
REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue
- Status
- COMPLETED
- Phase
- NA
Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)
- Status
- RECRUITING
- Phase
- PHASE3
Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology
- Status
- RECRUITING
- Phase
- NA
Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PDL1 in Ovarian High Grade Serous Carcinoma
- Status
- COMPLETED
- Phase
- N/A
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1